Home

Creating Collaboration by Breaking Down Scientific Barriers

Cell on March 24, 2021: QBI Director Nevan Krogan and QBI COO Jacqueline Fabius describe QBI's approach to breaking down silos, fostering global collaborations, and sharing the lessons we have learned.

Latest QBI News on COVID-19

On January 25, 2021: New preclinical data shows a promising therapeutic for SARS-CoV-2 infection: Plitidepsin (Aplidin).

February

Home

Creating Collaboration by Breaking Down Scientific Barriers

Latest QBI News on COVID-19

WHAT IS QBI?

QBI fosters collaborations across the biomedical and the physical sciences, seeking quantitative methods to address pressing problems in biology and biomedicine. Watch the video:

Commemorating QBI's 5th Year Anniversary

We want to take the opportunity to thank you for your continued support and engagement. Join us in reflecting on the accomplishments we’ve achieved together in 5 years.

Cancer drug Aplidin shows promise as COVID therapy

SF Chronicle on January 25, 2021: After a yearlong search for existing drugs that might help COVID-19 patients, a promising candidate was identified by scientists at UCSF.

Plitidepsin 100 times more potent than remdesivir in human epithelial cells

Biorxiv on January 24, 2021: Scientists share in vitro data demonstrating antiviral activity of plitidepsin.

The Women of QCRG

Women scientists from the QBI Coronavirus Research Group speak to the sense of urgency that inspired such a multidisciplinary team to gather and strategically fight the COVID-19 pandemic.

Secret to killing COVID-19 variants may lie in targeting human protein

ABC 7 News on February 16, 2021: QCRG scientists are studying the mutated genes of the COVID-19 variants, hoping to figure out the best drugs to kill it.

QBI SCIENTISTS

Interview With Natalia Jura

QBI SCIENTISTS

Interview With Danica Fujimori

QBI SCIENTISTS

Interview With Brian Shoichet

QBI SCIENTISTS

Interview With Matt Jacobson

QBI SCIENTISTS

Interview With Kevan Shokat

QBI SCIENTISTS

Interview With David Agard

QBI SCIENTISTS

Interview With Jack Taunton

QBI SCIENTISTS

Interview with Tanja Kortemme

QBI SCIENTISTS

Interview With Charles Craik

February

Revealing enzyme functional architecture via high-throughput microfluidic enzyme kinetics

March

Transcription factor binding to DNA mismatches – a potential driver of increased mutagenesis at regulatory sites

April

A universal mechanism for activation of MST2 during Hippo signal transduction